Comments
Loading...

Aptose Biosciences

APTONASDAQ
Logo brought to you by Benzinga Data
$0.408000
00.00%
Pre-Market: 7:52 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$38.00
Lowest Price Target1
$5.00
Consensus Price Target1
$13.86

Aptose Biosciences (NASDAQ:APTO) Stock, Analyst Ratings, Price Targets, Forecasts

Aptose Biosciences Inc has a consensus price target of $13.86 based on the ratings of 7 analysts. The high is $38 issued by Cantor Fitzgerald on September 7, 2023. The low is $5 issued by Piper Sandler on April 3, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Canaccord Genuity, and Piper Sandler on June 14, 2024, May 16, 2024, and April 3, 2024, respectively. With an average price target of $6 between HC Wainwright & Co., Canaccord Genuity, and Piper Sandler, there's an implied 1370.59% upside for Aptose Biosciences Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
1
Apr
0
0
0
0
May
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Canaccord Genuity
Piper Sandler
RBC Capital
Cantor Fitzgerald

1calculated from analyst ratings

Analyst Ratings for Aptose Biosciences

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Aptose Biosciences (APTO) stock?

A

The latest price target for Aptose Biosciences (NASDAQ:APTO) was reported by HC Wainwright & Co. on June 14, 2024. The analyst firm set a price target for $7.00 expecting APTO to rise to within 12 months (a possible 1615.69% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Aptose Biosciences (APTO)?

A

The latest analyst rating for Aptose Biosciences (NASDAQ:APTO) was provided by HC Wainwright & Co., and Aptose Biosciences reiterated their buy rating.

Q

When was the last upgrade for Aptose Biosciences (APTO)?

A

There is no last upgrade for Aptose Biosciences

Q

When was the last downgrade for Aptose Biosciences (APTO)?

A

There is no last downgrade for Aptose Biosciences.

Q

When is the next analyst rating going to be posted or updated for Aptose Biosciences (APTO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aptose Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aptose Biosciences was filed on June 14, 2024 so you should expect the next rating to be made available sometime around June 14, 2025.

Q

Is the Analyst Rating Aptose Biosciences (APTO) correct?

A

While ratings are subjective and will change, the latest Aptose Biosciences (APTO) rating was a reiterated with a price target of $7.00 to $7.00. The current price Aptose Biosciences (APTO) is trading at is $0.41, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.